Cargando…

Atorvastatin in Combination with Pegylated Interferon and Ribavirin Provided High Rate of Sustained Virological Response in Patients with Genotype 3 Hepatitis C Virus

BACKGROUND: Chronic hepatitis C virus infection represents a more frequent cause of liver cirrhosis and hepatocellular carcinoma. Statins, inhibit HCV replication in vitro, enhance the antiviral effect of the already known antiviral drugs and reduce their resistance. AIM: To determine the impact of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todorovska, Beti, Caloska-Ivanova, Viktorija, Dimitrova-Genadieva, Magdalena, Trajkovska, Meri, Popova-Jovanovska, Rozalinda, Grivceva-Stardelova, Kalina, Licoska-Josifovic, Fana, Andreevski, Vladimir, Curakova-Ristovska, Elena, Joksimovic, Nenad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Republic of Macedonia 2019
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560281/ https://www.ncbi.nlm.nih.gov/pubmed/31210815 http://dx.doi.org/10.3889/oamjms.2019.459

Ejemplares similares

NonHodgkin's Lymphoma with Peritoneal Localization
por: Curakova, E., et al.
Publicado: (2014)

Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators
por: Curakova Ristovska, Elena, et al.
Publicado: (2022)

The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1
por: Janeva, Elena Jovanovska, et al.
Publicado: (2015)

Relationship between Vitamin D, Inflammation and Lung Function In Patients with Severe Uncontrolled Asthma
por: Janeva-Jovanovska, Elena, et al.
Publicado: (2017)

Clinical Importance of Low Level of PAPP-A in First Trimester of Pregnancy - An Obstetrical Dilemma in Chromosomally Normal Fetus
por: Livrinova, Vesna, et al.
Publicado: (2019)

Obstetric Outcome in Pregnant Patients with Low Level of Pregnancy-Associated Plasma Protein A in First Trimester
por: Livrinova, Vesna, et al.
Publicado: (2018)

Safety Profile and Efficacy of Chemoembolization with Doxorubicin - Loaded Polyethylene Glycol Microspheres in Patients with Hepatocellular Carcinoma
por: Gjoreski, Aleksandar, et al.
Publicado: (2019)

TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma
por: Nikolova, Dafina, et al.
Publicado: (2018)

Distribution of Clostridium Difficile Ribotypes in Macedonian Patients and their Antimicrobial Susceptibility
por: Mihajlov, Kiril, et al.
Publicado: (2019)

Prevalence, Gender Distribution and Presence of Attention Deficit Hyperactivity Disorder by Certain Sociodemographic Characteristics Among University Students
por: Panevska, Lidija Sushevska, et al.
Publicado: (2014)

Relationship Between ADHD and Depression Among University Students in Macedonia
por: Panevska, Lidija Sushevska, et al.
Publicado: (2015)

The outcome of Pregnancy with Fetal Primitive Neuroectodermal Tumor
por: Livrinova, Vesna, et al.
Publicado: (2018)

Substance Use and Perceived Hassles among Junior Medical Students with High Anxiety Levels in the Republic of Macedonia
por: MANCEVSKA, Sanja, et al.
Publicado: (2014)

Ribavirin
Publicado: (2016)

Ribavirin
por: Hall, Caroline Breese
Publicado: (1985)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
por: Cho, Hyun Chin, et al.
Publicado: (2013)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
por: Carvalho-Filho, Roberto J, et al.
Publicado: (2010)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

The Connection of the Level of Estradiol in Serum and Obesity with the Endometrial Bleeding in Postmenopausal Women
por: Tofiloska, Valentina, et al.
Publicado: (2019)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
por: Karino, Y, et al.
Publicado: (2014)

Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or Atorvastatin
por: Ekstrand, Matias, et al.
Publicado: (2015)

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
por: Chak, Eric, et al.
Publicado: (2010)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Red Blood Cell Variables in Children and Adolescents regarding the Age and Sex
por: PLUNCEVIC GLIGOROSKA, Jasmina, et al.
Publicado: (2019)

“Bladder Effect” - An Urodynamic Parameter to Distinguish Subtypes of Urinary Incontinence in Women
por: Stojchevski, Sasho, et al.
Publicado: (2018)

Analysis of Body Mass Components in National Club Football Players in Republic of Macedonia
por: Nikolic, Slobodan, et al.
Publicado: (2014)

Ribavirin Concentrations Do Not Predict Sustained Virological Response in HIV/HCV-Coinfected Patients Treated with Ribavirin and Pegylated Interferon in the Swiss HIV Cohort Study
por: Kovari, Helen, et al.
Publicado: (2015)

Cutaneous side effects of combination therapy of pegylated interferon 2α and ribavirin
por: Raducan, Anca, et al.
Publicado: (2014)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
por: Rodríguez-Lojo, R., et al.
Publicado: (2010)

Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon
por: Meyer, Douglas F., et al.
Publicado: (2010)

Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
por: Lee, Tae-Hee, et al.
Publicado: (2014)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
por: Feld, Jordan J., et al.
Publicado: (2018)

Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
por: Gallacher, Jennifer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4p7ee6sb77pob13dh91jlg9b2j